These CD11c- cells had a marked (>30%) increase in the percentage of CD80+, CD86+, MHC class II+ and PD-L1+ cells (with no differences in PD-L2+ cells) (Figure 3D) when differentiated with RA, consistent with an activated regulatory phenotype in these cells described previously [35]. The gene discussed is CD86; the disease is rheumatoid arthritis.